Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex. (Record no. 26804727)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02804 a2200817 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517134244.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201712s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 2159-8290 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1158/2159-8290.CD-16-0653 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Zawistowski, Jon S |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20171219 |
245 00 - TITLE STATEMENT | |
Title | Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Cancer discovery |
Date of publication, distribution, etc. | 03 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 302-321 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Azepines |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Cycle Proteins |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line, Tumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | DNA Methylation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Discoidin Domain Receptor 1 |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance, Neoplasm |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Synergism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Enhancer Elements, Genetic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Epigenesis, Genetic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Heterocyclic Compounds, 4 or More Rings |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | MAP Kinase Kinase 1 |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | MAP Kinase Kinase 2 |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, Inbred BALB C |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, SCID |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Molecular Targeted Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nuclear Proteins |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Positive Transcriptional Elongation Factor B |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridones |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrimidinones |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | RNA Interference |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Transcription Factors |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Triazoles |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Triple Negative Breast Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bevill, Samantha M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Goulet, Daniel R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stuhlmiller, Timothy J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Beltran, Adriana S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Olivares-Quintero, Jose F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Singh, Darshan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sciaky, Noah |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Parker, Joel S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rashid, Naim U |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chen, Xin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Duncan, James S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Whittle, Martin C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Angus, Steven P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Velarde, Sara Hanna |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Golitz, Brian T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | He, Xiaping |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Santos, Charlene |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Darr, David B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gallagher, Kristalyn |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Graves, Lee M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Perou, Charles M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Carey, Lisa A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Earp, H Shelton |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Johnson, Gary L |
773 0# - HOST ITEM ENTRY | |
Title | Cancer discovery |
Related parts | vol. 7 |
-- | no. 3 |
-- | p. 302-321 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1158/2159-8290.CD-16-0653">https://doi.org/10.1158/2159-8290.CD-16-0653</a> |
Public note | Available from publisher's website |
No items available.